{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:28:18Z","timestamp":1793633298721,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.thromres.2026.109611","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:51:30Z","timestamp":1770252690000},"page":"109611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Patient adherence and satisfaction with self-administration of prophylactic Low Molecular Weight Heparin (LMWH) after orthopaedic trauma surgery: a prospective observational cohort study"],"prefix":"10.1016","volume":"259","author":[{"family":"Ebru Horzum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pieta Krijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem Maarten","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Birgitta","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2026.109611_bb0005","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/cdt.2017.09.01","article-title":"Deep vein thrombosis: pathogenesis, diagnosis, and medical management","volume":"7","author":"Stone","year":"2017","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"23 Suppl 1","key":"10.1016\/j.thromres.2026.109611_bb0010","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2026.109611_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0003319701052001S01","article-title":"Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence","volume":"20","author":"Nicolaides","year":"2001","journal-title":"Int. Angiol."},{"issue":"12","key":"10.1016\/j.thromres.2026.109611_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2024.111964","article-title":"VTE rates and risk factors in major trauma patients","volume":"55","author":"Bassa","year":"2024","journal-title":"Injury"},{"key":"10.1016\/j.thromres.2026.109611_bb0025","author":"Specialisten"},{"key":"10.1016\/j.thromres.2026.109611_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2016.03.026","article-title":"Risk factors for venous thromboembolism after acute trauma: a population-based case-cohort study","volume":"144","author":"Park","year":"2016","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109611_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109611_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med. Care"},{"key":"10.1016\/j.thromres.2026.109611_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/PPA.S240179","article-title":"Adherence to subcutaneous anti-TNF treatment in chronic inflammatory rheumatism and therapeutic patient education","volume":"14","author":"Fayet","year":"2020","journal-title":"Patient Prefer. Adher."},{"issue":"8","key":"10.1016\/j.thromres.2026.109611_bb0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/RHU.0000000000000320","article-title":"Adherence to anti-tumor necrosis factor therapy administered subcutaneously and associated factors in patients with rheumatoid arthritis","volume":"21","author":"Salaffi","year":"2015","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.thromres.2026.109611_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/jod.jod_64_23","article-title":"Determinants of medication adherence and impact of mobile telephony, pillbox interventions on compliance and glycemic control among patients with type 2 diabetes","volume":"15","author":"Verma","year":"2024","journal-title":"J. Diabetol."},{"key":"10.1016\/j.thromres.2026.109611_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2016.07.011","article-title":"Therapy adherence in non-Dutch speaking patients. Master Thesis in Family Medicine (in Dutch), Catholic University Leuven, Belgium (2015). https:\/\/www.icho-info.be [Accessed 25 June 2025]","volume":"120","author":"Gomes","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.thromres.2026.109611_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1477-7525-10-120","article-title":"The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients","volume":"10","author":"Cano","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.thromres.2026.109611_bb0070","series-title":"Master Thesis in Family Medicine (in Dutch), Catholic University Leuven, Belgium","first-page":"2015","article-title":"Therapy adherence in non-Dutch speaking patients","author":"Gibson","year":"2015"},{"issue":"4","key":"10.1016\/j.thromres.2026.109611_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/ijgc-2019-000284","article-title":"Patients\u2019 experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study","volume":"29","author":"Marchocki","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.thromres.2026.109611_bb0080","first-page":"453","article-title":"Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study","volume":"8","author":"Seaman","year":"2014","journal-title":"Patient Prefer. Adher."},{"issue":"6","key":"10.1016\/j.thromres.2026.109611_bb0085","first-page":"633","article-title":"Compliance with Low Molecular Weight Heparin in abulatory orthopedic patients","volume":"8","author":"Karli\u0144ski","year":"2006","journal-title":"Ortop. Traumatol. Rehabil."},{"issue":"1","key":"10.1016\/j.thromres.2026.109611_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jth.13563","article-title":"Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice","volume":"15","author":"van der Wall","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109611_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cjtee.2022.06.004","article-title":"The effects of information platform-based nursing on preventing venous thromboembolism in patients with hip fractures","volume":"25","author":"Gao","year":"2022","journal-title":"Chin. J. Traumatol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109611_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jhm.2282","article-title":"Patient preferences regarding pharmacologic venous thromboembolism prophylaxis","volume":"10","author":"Wong","year":"2015","journal-title":"J. Hosp. Med."},{"issue":"8","key":"10.1016\/j.thromres.2026.109611_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016676","article-title":"Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment","volume":"7","author":"Haac","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.thromres.2026.109611_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2026.109611_bb0115","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.asjsur.2024.02.113","article-title":"The safety and efficacy of NOACs versus LMWH for thromboprophylaxis after THA or TKA: a systemic review and meta-analysis","volume":"47","author":"Ding","year":"2024","journal-title":"Asian J. Surg."},{"issue":"3","key":"10.1016\/j.thromres.2026.109611_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2205973","article-title":"Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture","volume":"388","author":"O\u2019Toole","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109611_bb0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jss.2020.10.009","article-title":"Direct oral anticoagulants are a potential alternative to low-molecular-weight heparin for thromboprophylaxis in trauma patients sustaining lower extremity fractures","volume":"258","author":"Nederpelt","year":"2021","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109611_bb0130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.injury.2021.11.052","article-title":"Equivalence of DOACS and LMWH for thromboprophylaxis after hip fracture surgery: Systematic review and meta-analysis","volume":"53","author":"Nederpelt","year":"2022","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.thromres.2026.109611_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12957-024-03341-5","article-title":"Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis","volume":"22","author":"Zhou","year":"2024","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109611_bb0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH13-08-0666","article-title":"A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment","volume":"111","author":"Turpie","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2026.109611_bb0145","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s11136-014-0662-3","article-title":"Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates","volume":"23","author":"Reynolds","year":"2014","journal-title":"Qual. Life Res."},{"issue":"5","key":"10.1016\/j.thromres.2026.109611_bb0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0145721716655400","article-title":"Evaluation of the Measurement Properties of Self-reported Medication Adherence Instruments Among People at Risk for Metabolic Syndrome: A Systematic Review","volume":"42","author":"Kim","year":"2016","journal-title":"Diab. Educ."},{"issue":"8","key":"10.1016\/j.thromres.2026.109611_bb0155","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.21037\/apm-21-1878","article-title":"Reliability and validity of a modified 8-item Morisky Medication Adherence Scale in patients with chronic pain","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.thromres.2026.109611_bb0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fphar.2019.00168","article-title":"Self-reported medication adherence measured with morisky medication adherence scales and its determinants in hypertensive patients aged \u226560 years: a systematic review and meta-analysis","volume":"10","author":"Uchmanowicz","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.thromres.2026.109611_bb0165","doi-asserted-by":"crossref","DOI":"10.2196\/19179","article-title":"Measurement properties of existing patient-reported outcome measures on medication adherence: systematic review","volume":"22","author":"Kwan","year":"2020","journal-title":"J. Med. Internet Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:47:26Z","timestamp":1793630846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S0049384826000307"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109611","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient adherence and satisfaction with self-administration of prophylactic Low Molecular Weight Heparin (LMWH) after orthopaedic trauma surgery: a prospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109611"}}